Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 13, 2012 - Issue 9
Submit an article Journal homepage
245
Views
4
CrossRef citations to date
0
Altmetric
Drug Evaluations

Oxybutynin gel for the treatment of overactive bladder

Alex GomelskyLouisiana State University Health Sciences Center – Shreveport, 1501 Kings Highway, Shreveport, LA 71130, USA
, MD &
Roger R DmochowskiVanderbilt University Medical Center, Department of Urologic Surgery, A-1302, Medical Center North, Nashville, TN 37232, USA+1 615 343 5602; +1 615 322 8990; [email protected]
, MD FACS
Pages 1337-1343 | Published online: 21 May 2012

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Willem de Laat, Lisa Pagan, R. Karl Malcolm, Maarten Wiegerinck, Victor Nickolson, Bertine Huisman, Rik Stuurman, Michiel van Esdonk & Naomi Klarenbeek. (2023) First-in-human study to assess the pharmacokinetics, tolerability, and safety of single-dose oxybutynin hydrochloride administered via a microprocessor-controlled intravaginal ring. Drug Delivery 30:1.
Read now

Articles from other publishers (3)

Joshua A. Cohn, Elizabeth T. Brown, W. Stuart Reynolds, Melissa R. Kaufman, Douglas F. Milam & Roger R. Dmochowski. (2016) An update on the use of transdermal oxybutynin in the management of overactive bladder disorder. Therapeutic Advances in Urology 8:2, pages 83-90.
Crossref
D. Prasanthi & P. K. Lakshmi. (2013) Synergistic effect of iontophoresis and chemical enhancers on transdermal permeation of tolterodine tartrate for the treatment of overactive bladder. International braz j urol 39:1, pages 63-76.
Crossref
Philip E. V. Van Kerrebroeck. (2012) Does Conservative Management Really Benefit Patients with OAB?. Current Urology Reports 13:5, pages 348-355.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.